Speech-Language Pathologists in New York, NY Accepting Medicare
2354 Speech-Language Pathologists found. Showing 181 - 200
 Miss Valentina Lilian Mlikota Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 60 Madison Ave, 8th Floor, New York, NY 10010 Phone: 212-684-0099 |
Elizabeth Hanley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 55 E 120th St, New York, NY 10035 Phone: 212-369-3134 |
Sonia Hon Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 240 E 38th St, New York, NY 10016 Phone: 347-741-1243 |
Meagan Gaffney, M.S., CF-SLP, TSSLD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 134 W 26th St, Suite #602, New York, NY 10001 Phone: 845-570-1200 |
Jenna S Shapiro Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 509 W 129th St, New York, NY 10027 Phone: 212-505-1878 |
Emily Schwartz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 575 8th Ave Fl 6, New York, NY 10018 Phone: 917-286-4261 Fax: 917-286-4261 |
Pilar Aquino Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 509 W 129th St, New York, NY 10027 Phone: 212-543-4460 |
Amy Tesser Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 270 W 70th St, New York, NY 10023 Phone: 212-799-1033 |
Jena Vecchio Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 215 W 114th St, New York, NY 10026 Phone: 646-569-5920 |
Kacie Mcgoldrick Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 E 30th St, New York, NY 10016 Phone: 212-810-4120 |
Elizabeth Francis Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 W 111th St, New York, NY 10026 Phone: 212-410-0566 |
Disha Bowens Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 575 8th Ave Fl 6, New York, NY 10018 Phone: 917-286-4261 |
 Andrew Kenneth Christler, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 458 W 52nd St Apt 2d, New York, NY 10019 Phone: 313-421-2166 |
Hannah Yi Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 535 5th Ave Fl 4, New York, NY 10017 Phone: 718-948-1900 |
Ms. Carly Dash Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 148 W 90th St, New York, NY 10024 Phone: 212-787-7070 |
Kayla Sullivan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 293 E Broadway, New York, NY 10002 Phone: 212-673-4470 |
Jessica Bottone Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 622 W 168th St, 10th Floor, Room 1001, New York, NY 10032 Phone: 212-305-2238 |
Linda M Carroll, PHD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 424 W 49th St, Suite 1, New York, NY 10019 Phone: 212-459-3929 Fax: 212-459-2585 |
Ms. Beth M Levetown, MA CCC BILINGUAL SPL Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 210 E 86th St, Suite 202, New York, NY 10028 Phone: 201-315-7579 |
 Innovative Therapy Solutions Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1330 5th Ave, 6i, New York, NY 10026 Phone: 646-922-4002 |
News Archive
Biologic treatments reduce mortality risk in patients with rheumatoid arthritis
According to a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, patients with rheumatoid arthritis (RA) who are prescribed biologic treatments have a significantly lower mortality risk (adjusted hazard ratio [HR]: 0.61) than those just treated with traditional disease modifying anti-rheumatic drugs (DMARDs).The study also found the mortality was similar irrespective of the method of action of biologics (anti-tumour necrosis factor drugs [anti-TNFs] or rituximab).
FDA approves St. Jude Medical's Penta surgical lead for neurostimulation therapy
St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta™ surgical lead for neurostimulation therapy. Unveiled at the annual North American Neuromodulation Society meeting, the Penta lead is the first of its kind, featuring the smallest electrodes in the market arranged in five columns.
Dry umbilical cord care in developing countries should be reconsidered
A topical antiseptic reduces umbilical cord infections and infant mortality risk, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health.
Researchers identify new paradigm for regulation of alternative splicing
How a T cell decides to make protein X, Y, or Z can have profound effects for fighting foreign invaders or staving off dire autoimmune reactions. Researchers at the University of Pennsylvania School of Medicine have identified the steps that control how different forms of an immune cell protein called CD45, which is critical for activating the immune system when faced with pathogens, are controlled in the arc of a body's immune response.
Florida stands out among states with refusal to accept federal health law funding
The New York Times reports on strict stand by Florida governor to avoid HHS money. Meanwhile, other news outlets look at funding for insurance co-ops, efforts to set up health exchanges, and reviews of insurance premium increases.
› Verified 8 days ago
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Chiropractors
Optometrists
Podiatrists
Audiologists